Researchers from McGill University Discuss Findings in Cancer (Survival Benefit Associated With Participation In Clinical Trials of Anticancer Drugs: a Systematic Review and Meta-analysis).

A report from researchers at McGill University in Montreal, Canada discusses the findings of a systematic review and meta-analysis on the survival benefit associated with participation in clinical trials of anticancer drugs. The researchers aimed to determine whether participating in cancer trials was associated with greater survival benefit compared to routine care. The meta-analysis revealed a statistically significant overall survival benefit for trial participants, but this benefit diminished when studies controlled for bias and confounders. The researchers concluded that pooled results of high-quality studies do not consistently show a beneficial effect of trial participation on its own. [Extracted from the article]